FNWB First Northwest Bancorp Insider Trading

FNWB CEO Queyrouze purchases 4,770 shares at $10.41 amid -23.1% revenue decline and prior-year loss

Queyrouze Curt, the President and CEO of First Northwest Bancorp, purchased 4,770 shares at $10.41 on 2026-02-06, increasing his holdings from 50,000 to 54,770 shares. The transaction occurs as the company faces significant headwinds: annual revenue declined 23.1% year-over-year and the company was unprofitable over its most recent full fiscal year. The stock currently trades at $10.25, 13.7% below its 52-week high of $11.88, though it has appreciated 11.4% over the past 90 days. An insider open-market purchase by the CEO warrants attention in the context of deteriorating financial performance, particularly to assess whether this reflects private information about stabilization or turnaround prospects, or simply routine portfolio activity unrelated to company fundamentals.

EVP Kyle Henderson buys 3,000 FNWB shares at $7.74; stock -34.8% from 52-week high amid -$9.0M net loss.

Henderson Kyle David, EVP and Chief Credit Officer, purchased 3,000 shares at $7.74 on 2025-07-28, increasing his holdings by 22.6% to 16,271 shares. The transaction occurs while the stock is trading -34.8% from its 52-week high of $11.88 and the company faces material headwinds: a negative net income of $-9,036,000.00 and annual revenue decline of -23.1%. Notably, Henderson's sole prior transaction at FNWB (a buy on 2024-07-29) achieved a positive 90-day return of +1.0%, demonstrating a pattern of well-timed entry points at this specific ticker. The modest current 30-day return of +0.6% and -24.0% over 90 days post-transaction show a depressed valuation environment; however, the company's unprofitable state and revenue contraction warrant attention to the underlying business fundamentals driving the stock weakness.

CEO DEINES bought 2,500 shares of FNWB at $8.30 on 2025-06-03; stock down 28.9% from 52-week high amid -23.1% revenue decline and $-9.0M annual loss.

DEINES MATTHEW (President / CEO) purchased 2,500 shares at $8.30, raising his holdings to 117,262 shares. The transaction occurs in a materially deteriorated context: the company reported a $-9,036,000.00 net loss and annual revenue contracted by 23.1% year-over-year. The stock has declined 28.9% from its 52-week high of $11.88 and dropped 19.4% over the past 90 days, trading at $8.45 (current price). Within FNWB-specific history, DEINES has executed 4 prior open-market purchases; of those, 2 generated positive 90-day returns (2024-11-05: +11.3%, 2024-03-07: -34.7%, 2024-07-29: -4.0%, 2023-03-17: +6.5%), indicating a mixed timing record at this ticker. His cross-ticker track record across all positions shows a 50.00% 90-day win rate with an average 90-day return of -5.2%. The purchase at current depressed valuation in a context of significant operational headwinds and a documented pattern of mixed execution success warrants close investor review of the company's turnaround prospects and the insider's conviction level.

Director Galanda buys 1,000 FNWB shares at $10.81 amid -23.1% revenue decline and -$2.0M net loss

Galanda Gabriel Steven, a Director, purchased 1,000 shares at $10.81 on 2025-04-28, increasing his holdings from 9,033 to 10,033 shares. This acquisition occurs against a backdrop of deteriorating fundamentals: the company posted a net loss of -$2.0M over its most recent full fiscal year and experienced annual revenue growth of -23.1%. The transaction price of $10.81 sits between the current market price of $10.23 (roughly 5.7% below transaction price) and the 52-week high of $11.88, placing it in mid-range valuation territory. The absence of a coordinated buying pattern or scheduled trading plan in this filing limits any inference to this single insider's activity.

FNWB Director Brennan buys 2,000 shares at $10.70; stock down 34.1% from 52-week high amid -23.1% revenue decline and -$2.0M net loss

Brennan Sean Patrick, a director at First Northwest Bancorp, purchased 2,000 shares at $10.70 on 2024-12-13, bringing his holdings to 9,104 shares and representing a 28.2% increase in his prior position. The purchase occurs against a backdrop of significant operational stress: the company reported a net loss of -$1,980,000.00 and annual revenue contraction of -23.1%, while the stock trades at a 34.1% discount from its 52-week high of $16.09. With a P/E ratio of 40.77 and market cap of $100,087,182.20, the company's valuation metrics reflect market skepticism amid the operational challenges. This insider acquisition into weakness warrants monitoring given the magnitude of recent financial deterioration and the depth of the stock's decline from recent peaks.

FNWB CEO Matthew Deines buys 2,100 shares at $9.79; stock down 36.5% from 52-week high of $16.09.

CEO Matthew Deines purchased 2,100 shares at $9.79, increasing his holdings to 102,951 shares. The purchase occurred when FNWB is trading at $10.22, which is -36.5% from the 52-week high of $16.09, suggesting the stock is near depressed levels. Deines' same-ticker history at FNWB shows mixed outcomes: his prior three buys achieved positive 90-day returns only 1 out of 3 times (33% success rate), with his most recent buy on 2024-07-29 delivering +2.1% over 30 days but -4.0% over 90 days. Broader fundamentals raise caution: annual revenue has declined 23.1% year-over-year, the P/E of 39.31 is elevated, and net income stands at only $1.4M against a $96.5M market cap. The purchase is modest relative to existing holdings (+2.1%), and without additional context on insider motivation or market conditions, this represents a routine insider acquisition by a CEO of a small-cap regional bank experiencing contraction.

CEO Matthew Deines bought 9,285 shares of FNWB at $10.79 on 2024-07-29 for $100,188.80; stock now -36.5% from 52-week high.

Matthew Deines, President/CEO, purchased 9,285 shares at $10.79, increasing his holdings by 9.2% to 110,740 shares post-transaction. The stock has since declined to $10.21, trading -36.5% from its 52-week high of $16.09, while his prior buy at FNWB on 2024-03-07 resulted in a -34.7% 90-day decline. Fundamentally, the company reports -23.1% annual revenue growth and a 39.27 P/E ratio on $396,000 in net income. The transaction occurred as 2 other insiders also bought within the past 14 days, forming a cluster buying pattern during a period of significant stock depreciation and weak revenue momentum.

Director Anderson buys 150 shares at $10.75; cluster of 3 insiders buying in 14 days amid -23.1% revenue decline

Director Anderson Sherilyn G purchased 150 shares at $10.75, raising her post-transaction holdings to 10,192 shares from 10,042 shares. This transaction occurs within a cluster pattern: 2 other insiders also bought within the past 14 days, suggesting coordinated or parallel accumulation at this price level. The broader context shows material headwinds: the company posted -23.1% annual revenue decline and carries a steep P/E of 39.27, while the stock is -36.5% from its 52-week high of $16.09. The small transaction size ($1,612.50) and modest 1.5% increase to holdings suggests modest conviction rather than aggressive repositioning. The cluster buy pattern warrants attention as potential signal of insider assessment of value at current levels, particularly against the backdrop of revenue contraction.

CCO Henderson Kyle David buys 1,000 FNWB shares at $10.26; 2 other insiders bought within 14 days

Henderson Kyle David, Chief Credit Officer, purchased 1,000 shares at $10.26 on 2024-07-29, increasing his holdings to 3,100 shares post-transaction. This buy occurs within a cluster pattern: 2 other insiders also purchased shares within the past 14 days, suggesting coordinated or mutually-reinforced accumulation during a period when FNWB traded at -35.6% from its 52-week high of $16.09. The stock has recovered +7.0% over the past 30 days from depressed levels, yet the company faces headwinds with annual revenue decline of -23.1% and an elevated P/E of 39.88 against modest net income of $396.0K, raising questions about the quality of the rebound and whether the cluster buying reflects conviction or a response to valuation dislocation.